Kezar Life Sciences Company
Kezar Life Sciences company focused on the discovery and development of drugs targeting protein homeostasis for autoimmune disorders
%20.jpg)
Founded Date:
2015
Total Funding:
$78.3M
Investor Type:
N/A
Employee Number:
11-50
Investment Stage:
N/A
Funding Status:
IPO
Number Of Exists:
N/A
Technology:
Data-driven Technologies
Last Funding Type:
Series B
Investors Number:
10
Industry:
PharmTech
Headquarters:
South San Francisco, California, United States
Estimated Revenue:
$1M to $10M